Spark to IPO to fund 'first US gene therapy approval'
This article was originally published in Scrip
Executive Summary
Spark Therapeutics, which raised $72.8m in Series B venture capital in May 2014, just seven months after a $50m Series A round (scripintelligence.com, 31 May 2014), has filed for an initial public offering to raise $86m.